The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
Open accessAbstract
Background & Aims Adenosine mediates immune suppression and is generated by the ectonucleotidases CD39 (ENTPD1) and CD73 that are expressed on vascular endothelial cells and regulatory T cells (Treg). Although tumor-infiltrating immune cells include Foxp3+ Treg, it is not clear whether local adenosine generation by Treg promotes tumor growth in a CD39-dependent manner. In this study, we have examined the impact of CD39 expression by Treg on effector immune cell responses to hepatic metastases in vivo. Methods and Results A model of hepatic metastatic cancer was developed with portal vein infusion of luciferase-expressing melanoma B16/F10 cells and MCA38 colon cancer cells in wild type and mutant mice null for Cd39. Chimeric mice were generated by bone marrow transplantation (BMT) using Cd39 null or wild type (wt) C57BL6 donors and irradiated recipient mice. We demonstrate that hepatic growth of melanoma metastatic tumors was strongly inhibited in mice with Cd39 null vasculature or in wild type mice with circulating Cd39 null bone marrow-derived cells. We show functional CD39 expression on CD4+Foxp3+ Treg suppressed anti-tumor immunity mediated by NK cells in vitro and in vivo. Lastly, inhibition of CD39 activity by POM-1 (polyoxometalate-1), a pharmacological inhibitor of NTPDase activity, significantly inhibited tumor growth (P < .001). Conclusions CD39 expression on Treg inhibits NK activity and is permissive for metastatic growth. Pharmacological or targeted inhibition of CD39 enzymatic activity may find utility as an adjunct therapy for secondary hepatic malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Self-citationMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Self-citationRhule, J. T., Hill, C. L., Judd, D. A., & Schinazi, R. F. (1998) · Chemical Reviews · doi:10.1021/cr960396q · Cited by 1,892
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Increase of regulatory T cells in the peripheral blood of cancer patients.
Wolf, A. M., Wolf, D. G. F., Steurer, M., Gastl, G. A., Gunsilius, E., & Grubeck-Loebenstein, B. (2003) · PubMed · Cited by 891
Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase
Kaczmarek, E., Koziak, K., Sévigny, J., Siegel, J. B., Anrather, J., Beaudoin, A. R., Bach, F. H., & Robson, S. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33116 · Cited by 583
Self-citationAnti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Enjyoji, K., Sévigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S. A., Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., et al. (1999) · Nature Medicine · doi:10.1038/12447 · Cited by 565
Self-citationClose encounters of different kinds: Dendritic cells and NK cells take centre stage
Degli-Esposti, M. A., & Smyth, M. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1549 · Cited by 554
Haskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Ecto-ATPases: Identities and Functions
Plesner, L. (1995) · International Review of Cytology · doi:10.1016/s0074-7696(08)62487-0 · Cited by 501
Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications
Hasenknopf, B. (2005) · Frontiers in Bioscience · doi:10.2741/1527 · Cited by 459
Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., & Fu, Y.-X. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041684 · Cited by 432
CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer
Smyth, M. J., Teng, M. W. L., Swann, J., Kyparissoudis, K., Godfrey, D. I., & Hayakawa, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1582 · Cited by 420
Purinergic Signaling and Vascular Cell Proliferation and Death
Burnstock, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105360 · Cited by 414
Differential antitumor immunity mediated by NKT cell subsets in vivo
Crowe, N. Y., Coquet, J. M., Berzins, S. P., Kyparissoudis, K., Keating, R., Pellicci, D. G., Hayakawa, Y., Godfrey, D. I., & Smyth, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050953 · Cited by 392
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Lakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36022 · Cited by 347
Mizumoto, N., Kumamoto, T., Robson, S. C., Sévigny, J., Matsue, H., Enjyoji, K., & Takashima, A. (2002) · Nature Medicine · doi:10.1038/nm0402-358 · Cited by 327
Self-citationTumor-promoting functions of adenosine
Spychala, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00053-x · Cited by 284
Ghiringhelli, F., Ménard, C., Martin, F., & Zitvogel, L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00445.x · Cited by 273
Hoskin, D., Mader, J., Furlong, S., Conrad, D., & Blay, J. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.527 · Cited by 242
Improving T Cell Therapy for Cancer
Leen, A. M., Rooney, C. M., & Foster, A. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141527 · Cited by 240
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow–derived cells
Day, Y.-J., Huang, L., McDuffie, M. J., Rosin, D. L., Ye, H., Chen, J.-F., Schwarzschild, M. A., Fink, J. S., Linden, J., & Okusa, M. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15483 · Cited by 231
Antitumor Activity of IFN-λ in Murine Tumor Models
Sato, A., Ohtsuki, M., Hata, M., Kobayashi, E., & Murakami, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7686 · Cited by 195
Self-citationMandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E., Lang, S., Johnson, J. T., & Whiteside, T. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1143 · Cited by 182
Gs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells
Raskovalova, T., Huang, X., Sitkovsky, M., Zacharia, L. C., Jackson, E. K., & Gorelik, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4383 · Cited by 175
Control of NK cell functions by CD4+CD25+ regulatory T cells
Ralainirina, N., Poli, A., Michel, T., Poos, L., Andrès, E., Hentges, F., & Zimmer, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606409 · Cited by 170
Disordered Cellular Migration and Angiogenesis in cd39- Null Mice
Goepfert, C., Sundberg, C., Sévigny, J., Enjyoji, K., Hoshi, T., Csizmadia, E., & Robson, S. C. (2001) · Circulation · doi:10.1161/hc5001.100663 · Cited by 154
Self-citationHost A2B Adenosine Receptors Promote Carcinoma Growth
Ryzhov, S. V., Novitskiy, S. V., Carbone, D. P., Biaggioni, I., Zaynagetdinov, R., Goldstein, A. E., Dikov, M. M., & Feoktistov, I. (2008) · Neoplasia · doi:10.1593/neo.08478 · Cited by 151
Lokshin, A. E., Raskovalova, T., Huang, X., Zacharia, L. C., Jackson, E. K., & Gorelik, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0478 · Cited by 138
Corriden, R., Chen, Y., Inoue, Y., Beldi, G., Robson, S. C., Insel, P. A., & JUNGER, W. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800039200 · Cited by 131
Self-citationRaskovalova, T., Lokshin, A. E., Huang, X., Jackson, E. K., & Gorelik, E. (2006) · Immunologic Research · doi:10.1385/ir:36:1:91 · Cited by 125
NK Cells Stimulate Proliferation of T and NK Cells through 2B4/CD48 Interactions
Assarsson, E., Kambayashi, T., Schatzle, J. D., Cramer, S. O., von Bonin, A., Jensen, P. E., Ljunggren, H., & Chambers, B. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.174 · Cited by 116
Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C., & Robson, S. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070190 · Cited by 113
Self-citationXu, D., Gu, P., Pan, P., Li, Q., Sato, A. I., & Chen, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.11696 · Cited by 110
Beldi, G., Wu, Y., Banz, Y., Nowak, M. A., Miller, L., Enjyoji, K., Haschemi, A., Yegutkin, G. G., Candinas, D., Exley, M. A., et al. (2008) · Hepatology · doi:10.1002/hep.22401 · Cited by 91
Self-citationHoskin, D. W., Reynolds, T., & Blay, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590625 · Cited by 90
Hilchey, S. P., Kobie, J. J., Cochran, M. R., Secor‐Socha, S., Wang, J.-C. E., Hyrien, O., Burack, R., Mosmann, T. R., Quataert, S. A., & Bernstein, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900475 · Cited by 87
Guido, G. (2007) · Frontiers in bioscience · doi:10.2741/2868 · Cited by 82
Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations
Zhou, Q., Yan, J., Putheti, P., Wu, Y., Sun, X., Toxavidis, V., Tigges, J., Kassam, N., Enjyoji, K., Robson, S. C., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02777.x · Cited by 79
Self-citationOgawa, T., Takayama, K., Takakura, N., Kitano, S., & Ueno, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700478 · Cited by 76
Huang, X., Wong, M. K. K., Yi, H., Watkins, S. C., Laird, A., Wolf, S. F., & Gorelik, E. (2002) · PubMed · Cited by 72
Banz, Y., Beldi, G., Wu, Y., Atkinson, B. T., Usheva, A., & Robson, S. C. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07230.x · Cited by 65
Self-citationMiller, J. S., Cervenka, T., Lund, J., Okazaki, I. J., & Moss, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7376 · Cited by 59
Adenosine receptors and modulation of natural killer cell activity by purine nucleosides.
Priebe, T. S., Platsoucas, C. D., & Nelson, J. A. (1990) · PubMed · Cited by 54
Purine nucleoside modulation of functions of human lymphocytes
Priebe, T. S., Platsoucas, C. D., Seki, H., et al. (1990) · Cellular Immunology · doi:10.1016/0008-8749(90)90208-9 · Cited by 26
Natural killer cells lack ecto-5'-nucleotidase.
Christensen, L., & Andersen, V. (1992) · PubMed · Cited by 14
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
CD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,263
Harnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
Metadata
- Authors
- Sun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Müller, C. E., Murakami, T., & Robson, S. C.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 139
- Issue
- 3
- Pages
- 1030-1040
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2029733235
- Cited by
- 279
- References
- 53
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.